Janet Woodcock and Sandoz

Selected healthcare news for the person - Janet Woodcock, and the company - Sandoz We have 10 shared news items for this connection to-date.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
4/24/2020 FDA’s Woodcock on authorizing emergency use for hydroxychloroquine: ‘We did the best we could’ STAT ... though there is no evidence the medicines may be useful in patients stricken by the novel coronavirus. We spoke with Janet Woodcock, who heads the FDA Center for Drug Evaluation and Research, about this decision ... a couple of drugs. There was a big donation by Sandoz, which is approved in the U.S. and was put into the EUA, but only distributed to hospitalized patients for Covid-19. We were pretty ...
3/12/2020 How much does U.S. rely on China for drugs? FDA simply doesn't know FiercePharma ... from China. So, how dependent is the U.S. on China for its drugs? The fact is, the FDA doesn’t know. Janet Woodcock, FDA’s director of the Center for Drug Evaluation and Research, in congressional testimony ... work for you. RELATED: Don't wait up. FTC delays Novartis' Sandoz deal with Aurobindo into 2020: report The White House is working on an executive order to close “loopholes allowing the government to purchase pharmaceuticals ...
11/13/2019 A tiny pharmacy raises big doubts about our drugs ... medicines approved by the FDA, and we are working with manufacturers and global regulators to provide clear and actionable information," Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research, said in a ... ranitidine manufacturers have also pulled their U.S. products, including Novartis's Sandoz division, Dr. Reddy's Laboratories and Apotex. Sandoz and Dr. Reddy's both cited "confirmed contamination" above FDA's limits in a statement. Apotex said its recall ...
11/8/2019 A tiny pharmacy raises big doubts about our drugs - SFGate ... medicines approved by the FDA, and we are working with manufacturers and global regulators to provide clear and actionable information," Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research, said in a ... ranitidine manufacturers have also pulled their U.S. products, including Novartis's Sandoz division, Dr. Reddy's Laboratories and Apotex. Sandoz and Dr. Reddy's both cited "confirmed contamination" above FDA's limits in a statement. Apotex said its recall ...
9/25/2019 FDA announces voluntary recall of Sandoz ranitidine capsules following detection of an impurity PR Newswire ... is alerting health care professionals and patients of a voluntary recall of 14 lots of prescription ranitidine capsules distributed by Sandoz Inc., used to decrease the amount of acid created by the stomach. This recall ... well as the potential risks from taking ranitidine products," said Janet Woodcock , M.D., director of the FDA's Center for Drug Evaluation and Research. The agency is testing ranitidine products from multiple manufacturers and assessing the ...
9/24/2019 FDA announces voluntary recall of Sandoz ranitidine capsules following detection of an impurity | Markets Insider Business Insider ... is alerting health care professionals and patients of a voluntary recall of 14 lots of prescription ranitidine capsules distributed by Sandoz Inc., used to decrease the amount of acid created by the stomach. This recall ... well as the potential risks from taking ranitidine products," said Janet Woodcock , M.D., director of the FDA's Center for Drug Evaluation and Research. The agency is testing ranitidine products from multiple manufacturers and assessing the ...
9/20/2019 Popular heartburn drug may be tainted with cancer-causing chemical Yahoo News ... low levels of NDMA, or N-Nitrosodimethylamine, which is a probable carcinogen, according to the U.S. Food and Drug Administration . Sandoz, the generic drug arm of Novartis, has halted worldwide distribution in the meantime. Some ... about the amounts of NDMA found in the heartburn drugs. Janet Woodcock, MD, director of the FDA's Center for Drug Evaluation and Research, said in a statement : "Although NDMA may cause harm in large amounts ...
9/19/2019 Drugmaker halts shipments of ranitidine heartburn medication after contaminant found - CNN CNN CNN) Drugmaker Novartis said it is halting distribution of all ranitidine medicines made by Sandoz, a measure it called "precautionary" after the acid-reducing medications were found to contain an impurity. Pharmacy tests turn up ... common foods," according to a statement last week from Dr. Janet Woodcock, research director for FDA's Centers for Drug Evaluation and Research. Woodcock said the agency is working with international regulators and industry partners to ...
9/19/2019 Drugmaker halts shipments of ranitidine heartburn medication after contaminant found - CNN CNN CNN) Drugmaker Novartis said it is halting distribution of all ranitidine medicines made by Sandoz, a measure it called "precautionary" after the acid-reducing medications were found to contain an impurity. Pharmacy tests turn up ... common foods," according to a statement last week from Dr. Janet Woodcock, research director for FDA's Centers for Drug Evaluation and Research. Woodcock said the agency is working with international regulators and industry partners to ...
9/13/2019 UPDATE 1-U.S and European regulators reviewing safety of heartburn drugs like Zantac Yahoo News ... drugs since last year, and the FDA expanded its investigation of the impurities beyond that class of drugs last month. Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research, said in an ... drugmakers such as Mylan NV, Teva Pharmaceutical Industries and Novartis' Sandoz, as the drugs have been found to contain probable carcinogens. (Reporting by Michael Erman in New York; Additional reporting by Manojna Maddipatla in Bengaluru ...